Evidence map›Paper›PMID 34567238›Full record

ArticleEnvironmental research letters : ERL [Web site]2021

Climate change, riverine flood risk and adaptation for the conterminous United States.

Cameron Wobus, Jeremy Porter, Mark Lorie, Jeremy Martinich, Rachel Bash

Abstract read
In one paragraph

Article in Environmental research letters : ERL [Web site], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cameron WobusLynker Technologies, Boulder CO USA 80303.
Jeremy PorterFirst Street Foundation, Brooklyn, NY USA 11201.
Mark LorieAbt Associates, Boulder CO USA 80301.
Jeremy MartinichUS Environmental Protection Agency, Washington DC USA 20460.
Rachel BashLynker Technologies, Boulder CO USA 80303.

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

Riverine floods are among the most costly natural disasters in the United States, and floods are generally projected to increase in frequency and magnitude with climate change. Faced with these increasing risks, improved information is needed to direct limited resources toward the most cost-effective adaptation actions available. Here we leverage a newly available flood risk dataset for residential properties in the conterminous United States to calculate expected annual damages to residential structures from inland/riverine flooding at a property-level; the cost of property-level adaptations to protect against future flood risk; and the benefits of those adaptation investments assuming both static and changing climate conditions. Our modeling projects that in the absence of adaptation, nationwide damages from riverine flooding will increase by 20-30% under high levels of warming. Floodproofing, elevation and property acquisition can each be cost-effective adaptations in certain situations, depending on the desired return on investment (i.e., benefit cost ratio), the discount rate, and the assumed rate of climate change. Incorporation of climate change into the benefit-cost calculation increases the number of properties meeting any specified benefit-cost threshold, as today's investments protect against an increasing frequency of future floods. However, because future expected damages are discounted relative to present-day, the adaptation decisions made based on a static climate assumption are very similar to the decisions made when climate change is considered. If the goal is to optimize adaptation decision making, a focus on quantifying present-day flood risk is therefore at least as important as understanding how those risks might change under a warming climate.

Identifiers

PMID34567238
PMCPMC8459676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.